查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1715539

血管假体市场按产品类型、血管直径、适应症、最终用户和分销管道划分－2025-2030 年全球预测

Vascular Graft Market by Product Type, Blood Vessel Diameter, Indication, End User, Distribution Channel - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 185 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计血管移植市场规模到 2024 年将达到 23 亿美元，到 2025 年将达到 24.7 亿美元，到 2030 年将达到 35.3 亿美元，复合年增长率为 7.39%。

主要市场统计数据
基准年2024年 23亿美元
预计2025年 24.7亿美元
预测年份 2030 35.3亿美元
复合年增长率（%） 7.39%

过去十年，受技术进步、微创手术需求增加以及精准医疗日益受到关注的推动，血管移植市场经历了显着增长。在当今的临床环境中，患者和医疗保健系统都需要耐用、生物相容的解决方案来管理血管疾病。这个充满活力的行业的特点是创新的产品开发和对改善患者治疗效果的坚定承诺。製造商已经改进了植入物的设计，以提高性能、减少併发症并与先进的手术技术无缝整合。越来越多的临床证据支持使用生物和合成选项，每种选项都根据患者特定因素和手术要求提供独特的优势。同时，法律规范也不断更新以应对技术创新，凸显了强有力的临床试验和上市后监测的迫切需求。随着市场竞争日益激烈，相关人员正在投资研发，以更好地满足未满足的需求。本介绍对市场区隔、区域动态、竞争格局进行了深入分析，并提出了策略建议，以指南产业领导者度过这段变革时期。后续叙述以这些主题为基础，强调新兴趋势、关键成长动力和下一代技术创新对血管移植市场的影响。

改变血管移植市场

随着新技术和临床创新重新定义传统实践，血管移植产业格局正在模式转移。近年来，手术方法已明显从传统方式转向更先进的微创技术，从而可以加快恢復速度并减少术后併发症。先进的移植材料和设计改进显着提高了植入装置的寿命和功能整合。新的生物工程技术为创造不仅耐用而且更紧密地模仿天然组织的植入物铺平了道路，从而提高了生物相容性和癒合效果。监管机构也在更新其指导方针，以跟上这些创新并确保新疗法符合高安全性和有效性标准。这种不断变化的环境促使传统製造商进行策略调整，与高科技创新者合作占领新的细分市场。数位健康解决方案和精准医疗的融合也发挥着越来越重要的作用，提供全面的监测和量身定制的治疗计划，以优化植入物的性能。相关人员现在有能力预测市场变化并相应地调整他们的投资策略。数据分析和人工智慧在产品开发和上市后监测中的整合进一步强调了这种转变，巩固了产业向更加以患者为中心和技术主导的未来发展。

血管假体市场的关键细分洞察

对市场区隔的详细分析可以对患者需求、产品创新和区域需求提供细緻的了解。在检查产品类型时，市场被仔细划分为生物血管移植物和合成血管移植物。人们对生物移植进行了进一步的研究，发现同种异体移植、自体移植和异质骨移植之间存在细微的差别，每种移植都有不同的临床特征和患者适用性。同时，对合成血管移植物进行了分析，重点关注聚酯、聚四氟乙烯和聚氨酯等材料配置，阐明了不同的性能指标和成本结构。除了产品类型之外，按血管直径进行细分还会引入额外的复杂性，即根据大血管和小血管对移植物进行分类。分析也涵盖了适应症，常见的手术包括主动脉绕道手术、脑动脉绕道手术、冠状动脉绕道术、下肢绕道手术、週边动脉绕道手术和肾动脉绕道手术。此外，它透过研究涵盖门诊手术中心、医院和诊所的最终用户来提供更详细的信息，同时透过线下和线上两种方式评估销售管道。如此详细的细分为竞争激烈的医疗保健行业的策略规划和市场定位提供了重要的可行见解。

目录

第一章 引言

第二章调查方法

第三章执行摘要

第四章 市场概述

第五章 市场洞察

  • 市场动态
    • 驱动程式
      • 心血管疾病的日益普及推动了对血管工程解决方案的需求。
      • 支持性政府法规和优惠报销政策鼓励腐败申请
    • 限制因素
      • 对血管移植相关产品召回和不利事件的担忧
    • 机会
      • 扩大 ACS 基础设施并优先进行非侵入性手术
      • 专注于血管内手术的自订和生物基血管移植物
    • 任务
      • 多区域法规环境和实现严格临床终点相关的挑战
  • 市场区隔分析
    • 产品类型：生物相容性为同种异体移植带来更大益处
    • 血管直径：扩大使用大直径血管移植物来恢復高流量血管的血流
    • 最终用户：增加门诊手术中心血管移植的使用，以缩短手术时间
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社会
    • 技术的
    • 合法的
    • 环境

第六章 血管假体市场（依产品类型）

  • 生物血管移植物
    • 同种异体移植
    • 自体移植
    • 异种移植
  • 合成血管移植物
    • 聚酯纤维
    • 聚四氟乙烯
    • 聚氨酯

第七章 人造血管市场（依血管直径）

  • 大的
  • 小的

第八章 血管假体市场（按适应症）

  • 主动脉髂动脉绕道手术
  • 脑动脉绕道手术
  • 冠状动脉绕道术
  • 下肢搭桥手术
  • 週边动脉绕道手术
  • 肾臟动脉绕道手术

第九章 血管假体市场（依最终使用者）

  • 门诊手术中心
  • 医院和诊所

第 10 章 血管假体市场（依通路）

  • 离线
  • 在线的

第 11 章：美洲血管移植市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

12. 亚太地区血管假体市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

13. 欧洲、中东和非洲血管移植市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十四章竞争格局

  • 2024年市场占有率分析
  • 2024年FPNV定位矩阵
  • 竞争情境分析
  • 战略分析与建议

公司名单

  • Abbott Laboratories
  • Affluent Medical
  • B. Braun Melsungen AG
  • Becton, Dickinson and Company
  • BIOVIC Sdn. Bhd.
  • Boston Scientific Corporation
  • Cardinal Health Inc.
  • Cook Medical, Inc.
  • Corcym Srl
  • CryoLife, Inc.
  • Endologix Inc.
  • Getinge AB
  • Heart Medical Europe BV
  • Japan Lifeline Co., Ltd.
  • Lemaitre Vascular, Inc.
  • Medtronic PLC
  • Merit Medical Systems, Inc.
  • Perouse Medical SAS by Vygon SAS
  • Rua Life Sciences PLC
  • Shanghai Suokang Medical Implants Co. Ltd.
  • Terumo Corporation
  • Vascular Graft Solutions Ltd.
  • VUP Medical
  • WL Gore & Associates, Inc.
  • Xeltis BV
Product Code: MRR-034B50030374

The Vascular Graft Market was valued at USD 2.30 billion in 2024 and is projected to grow to USD 2.47 billion in 2025, with a CAGR of 7.39%, reaching USD 3.53 billion by 2030.

KEY MARKET STATISTICS
Base Year [2024] USD 2.30 billion
Estimated Year [2025] USD 2.47 billion
Forecast Year [2030] USD 3.53 billion
CAGR (%) 7.39%

The vascular graft market has evolved significantly over the past decade, driven by technological advancements, increasing demand for minimally invasive procedures, and a growing focus on precision medicine. In today's clinical environment, patients and healthcare systems alike are searching for durable and biocompatible solutions to manage vascular conditions. This dynamic field is characterized by innovative product developments and a strong commitment to enhancing patient outcomes. Manufacturers have refined graft designs to improve performance, reduce complications, and integrate seamlessly with advanced surgical techniques. The growing body of clinical evidence supports the utilization of both biological and synthetic options, each offering unique advantages depending on patient-specific factors and surgical requirements. Meanwhile, regulatory frameworks continue to be updated in response to technological innovations, emphasizing the critical need for robust clinical studies and post-market surveillance. As the market becomes increasingly competitive, stakeholders are investing in research and development to address unmet needs with greater precision. This introduction sets the stage for an in-depth analysis of market segmentation, regional dynamics, competitive landscapes, and strategic recommendations that can guide industry leaders in navigating these transformative times. The narrative that follows builds on these themes, highlighting emerging trends, critical growth drivers, and the impact of next-generation innovations on the vascular graft market.

Transformative Shifts in the Vascular Graft Market Landscape

The landscape of the vascular graft industry is undergoing a paradigm shift as emerging technologies and clinical innovations redefine traditional practices. Recent years have witnessed a marked move from conventional surgical approaches to more sophisticated minimally invasive procedures, enabling faster recovery and reducing post-operative complications. Advanced graft materials and design improvements have greatly enhanced the life span and functional integration of implanted devices. New bioengineering techniques have opened up avenues to create grafts that are not only durable but also closely mimic natural tissue, thereby improving biocompatibility and healing outcomes. Regulatory bodies are adapting to these innovations with revised guidelines, ensuring that novel therapies meet high safety and efficacy standards. This evolving environment has led to strategic realignments where traditional manufacturers collaborate with high-tech innovators to capture new market segments. The convergence of digital health solutions and precision medicine is also playing an increasingly important role, offering comprehensive monitoring and tailored treatment plans that optimize graft performance. Stakeholders are now better equipped to anticipate market shifts and align their investment strategies accordingly. This shift is further underscored by the integration of data analytics and artificial intelligence in both product development and post-market surveillance, solidifying the industry's evolution towards a more patient-centric and technologically-driven future.

Key Segmentation Insights in Vascular Graft Markets

The detailed analysis of market segmentation offers a nuanced understanding of patient needs, product innovation, and regional demand. In inspecting the product type, the market is carefully divided into biological and synthetic vascular grafts. Biological grafts are studied further by the subtle differences among allografts, autografts, and xenografts, each possessing distinct clinical features and patient compatibility attributes. Simultaneously, synthetic vascular grafts are analyzed with a focus on material composition such as polyester, polytetrafluoroethylene, and polyurethane, shedding light on varied performance metrics and cost structures. Beyond product type, segmentation by blood vessel diameter introduces an additional layer of complexity by categorizing grafts based on large and small vessels, which informs both surgical decision-making and device customization. The analysis extends to indications, noting that common procedures include aortoiliac bypass surgery, cerebral artery bypass surgery, coronary artery bypass surgery, lower extremity bypass surgery, peripheral artery bypass surgery, and renal artery bypass surgery. Further granularity is provided by examining the end users which encompass both ambulatory surgical centers and hospitals & clinics, while distribution channels are evaluated across offline and online modalities. Such an in-depth segmentation provides actionable insights that are crucial for strategic planning and market positioning in a competitive healthcare industry.

Based on Product Type, market is studied across Biological Vascular Grafts and Synthetic Vascular Grafts. The Biological Vascular Grafts is further studied across Allografts, Autografts, and Xenografts. The Synthetic Vascular Grafts is further studied across Polyester, Polytetrafluoroethylene, and Polyurethane.

Based on Blood Vessel Diameter, market is studied across Large and Small.

Based on Indication, market is studied across Aortoiliac Bypass Surgery, Cerebral Artery Bypass Surgery, Coronary Artery Bypass Surgery, Lower Extremity Bypass Surgery, Peripheral Artery Bypass Surgery, and Renal Artery Bypass Surgery.

Based on End User, market is studied across Ambulatory Surgical Centers and Hospitals & Clinics.

Based on Distribution Channel, market is studied across Offline and Online.

Key Regional Insights Impacting the Vascular Graft Demand

The global distribution of the vascular graft market reveals distinct regional dynamics that are instrumental in shaping market strategies. In the Americas, a mature healthcare infrastructure combined with high adoption rates of advanced medical devices propels significant demand. There is consistent growth fueled by innovations in product technology and robust reimbursement policies that foster a favorable market environment. In the Europe, Middle East & Africa region, evolving demographic trends and increased healthcare spending drive market expansion. Here, regulatory reforms and strategic collaborations between local and multinational players have opened new avenues for clinical applications, thus broadening the market potential. Meanwhile, the Asia-Pacific region is emerging as a fast-growing frontier in this arena, bolstered by rapid economic growth, expanding healthcare access, and a rising prevalence of vascular diseases. Investments in state-of-the-art facilities and the acceleration of medical tourism further contribute to regional vibrancy. Each region, with its distinctive healthcare challenges and opportunities, underscores the importance of tailored marketing strategies and localized innovation to capture the nuanced demands of diverse patient populations while aligning with regional regulatory and economic conditions.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

Key Companies Shaping the Vascular Graft Market

Within the competitive ecosystem of the vascular graft market, several market leaders have distinguished themselves through continuous innovation, exceptional product quality, and expansive global reach. Notable industry players such as Abbott Laboratories, Affluent Medical, B. Braun Melsungen AG, Becton, Dickinson and Company, and BIOVIC Sdn. Bhd. have been instrumental in driving technological advancements and setting benchmarks for clinical efficacy. Other influential companies, including Boston Scientific Corporation, Cardinal Health Inc., Cook Medical, Inc., Corcym S.r.l., and CryoLife, Inc., have significantly contributed to expanding the portfolio of vascular graft offerings, focusing on both biological and synthetic solutions. Firms like Endologix Inc., Getinge AB, and Heart Medical Europe B.V. further enhance market competitiveness through strategic product innovations and aggressive R&D investments. Esteemed organizations such as Japan Lifeline Co., Ltd., Lemaitre Vascular, Inc., Medtronic PLC, Merit Medical Systems, Inc., and Perouse Medical SAS by Vygon SAS continue to innovate in device design and surgical compatibility. Additionally, Rua Life Sciences PLC, Shanghai Suokang Medical Implants Co. Ltd., Terumo Corporation, Vascular Graft Solutions Ltd., VUP Medical, W. L. Gore & Associates, Inc., and Xeltis B.V. play pivotal roles in pushing the boundaries of what is clinically achievable. Their combined efforts not only enhance patient care but also redefine the competitive dynamics of the vascular graft sector.

The report delves into recent significant developments in the Vascular Graft Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Affluent Medical, B. Braun Melsungen AG, Becton, Dickinson and Company, BIOVIC Sdn. Bhd., Boston Scientific Corporation, Cardinal Health Inc., Cook Medical, Inc., Corcym S.r.l., CryoLife, Inc., Endologix Inc., Getinge AB, Heart Medical Europe B.V., Japan Lifeline Co., Ltd., Lemaitre Vascular, Inc., Medtronic PLC, Merit Medical Systems, Inc., Perouse Medical SAS by Vygon SAS, Rua Life Sciences PLC, Shanghai Suokang Medical Implants Co. Ltd., Terumo Corporation, Vascular Graft Solutions Ltd., VUP Medical, W. L. Gore & Associates, Inc., and Xeltis B.V.. Actionable Recommendations for Industry Leaders in Vascular Grafts

For industry leaders seeking to capture the opportunities present in the dynamic vascular graft market, a multifaceted strategy is essential. First, investing in advanced research and development is crucial to harness innovations that improve graft biocompatibility and longevity. Collaborations with research institutions and leveraging data analytics can accelerate the development of next-generation products. Next, companies should focus on strategic partnerships that enhance regional market penetration while also expanding global footprints. An emphasis on tailoring products to meet the specific needs of diverse patient segments, whether based on product type, vessel diameter, or procedural indication, will prove beneficial. Additionally, companies are encouraged to adopt a robust digital transformation strategy by optimizing both online and offline distribution channels to ensure broader market access and increased consumer engagement. Proactive engagement with regulatory bodies to streamline approval processes is also recommended, ensuring that new innovations can be brought to market swiftly and safely. By aligning these strategies with a deep understanding of regional dynamics and competitive landscapes, industry leaders can sustainably drive growth, enhance clinical outcomes, and maintain a competitive edge in this rapidly evolving market.

Conclusion on the Future of Vascular Grafts

In summary, the vascular graft market is characterized by both significant challenges and substantial opportunities propelled by continuous medical innovations and evolving patient needs. The integration of advanced materials, innovative design approaches, and strategic segmentation has redefined how vascular conditions are managed globally. Key regional differences and robust competitive dynamics further underscore the importance of a tailored, agile approach to market strategy. Looking forward, companies that invest in research, engage in strategic partnerships, and adapt quickly to regulatory shifts are best positioned to lead the industry into the next phase of development. This evolving market promises not only improved patient outcomes through state-of-the-art graft solutions but also sustainable growth trajectories for forward-thinking organizations. As stakeholder focus intensifies on precision and customization, the path ahead is one of both dynamic change and steadfast opportunity.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing prevalence of cardiovascular diseases enhance the need for vascular graft solutions
      • 5.1.1.2. Supportive government regulations and favorable reimbursement policies enhancing graft applications
    • 5.1.2. Restraints
      • 5.1.2.1. Concerns associated with product recall and adverse findings related to vascular graft
    • 5.1.3. Opportunities
      • 5.1.3.1. Expanding ACS infrastructure and preferences for non-invasive surgeries
      • 5.1.3.2. Heightened focus on custom and biobased vascular grafts for endovascular surgeries
    • 5.1.4. Challenges
      • 5.1.4.1. Issues related to multi-regional regulatory landscapes and meeting rigorous clinical endpoints
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Product Type: Significant benefits of allografts owing to biological compatibility in treatment
    • 5.2.2. Blood Vessel Diameter: Expanding usage of large-diameter artificial blood vessels for restoring blood flow in high-flow vessels
    • 5.2.3. End User: Growing applications of vascular grafts in ambulatory surgical centers for reduced operative time
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Vascular Graft Market, by Product Type

  • 6.1. Introduction
  • 6.2. Biological Vascular Grafts
    • 6.2.1. Allografts
    • 6.2.2. Autografts
    • 6.2.3. Xenografts
  • 6.3. Synthetic Vascular Grafts
    • 6.3.1. Polyester
    • 6.3.2. Polytetrafluoroethylene
    • 6.3.3. Polyurethane

7. Vascular Graft Market, by Blood Vessel Diameter

  • 7.1. Introduction
  • 7.2. Large
  • 7.3. Small

8. Vascular Graft Market, by Indication

  • 8.1. Introduction
  • 8.2. Aortoiliac Bypass Surgery
  • 8.3. Cerebral Artery Bypass Surgery
  • 8.4. Coronary Artery Bypass Surgery
  • 8.5. Lower Extremity Bypass Surgery
  • 8.6. Peripheral Artery Bypass Surgery
  • 8.7. Renal Artery Bypass Surgery

9. Vascular Graft Market, by End User

  • 9.1. Introduction
  • 9.2. Ambulatory Surgical Centers
  • 9.3. Hospitals & Clinics

10. Vascular Graft Market, by Distribution Channel

  • 10.1. Introduction
  • 10.2. Offline
  • 10.3. Online

11. Americas Vascular Graft Market

  • 11.1. Introduction
  • 11.2. Argentina
  • 11.3. Brazil
  • 11.4. Canada
  • 11.5. Mexico
  • 11.6. United States

12. Asia-Pacific Vascular Graft Market

  • 12.1. Introduction
  • 12.2. Australia
  • 12.3. China
  • 12.4. India
  • 12.5. Indonesia
  • 12.6. Japan
  • 12.7. Malaysia
  • 12.8. Philippines
  • 12.9. Singapore
  • 12.10. South Korea
  • 12.11. Taiwan
  • 12.12. Thailand
  • 12.13. Vietnam

13. Europe, Middle East & Africa Vascular Graft Market

  • 13.1. Introduction
  • 13.2. Denmark
  • 13.3. Egypt
  • 13.4. Finland
  • 13.5. France
  • 13.6. Germany
  • 13.7. Israel
  • 13.8. Italy
  • 13.9. Netherlands
  • 13.10. Nigeria
  • 13.11. Norway
  • 13.12. Poland
  • 13.13. Qatar
  • 13.14. Russia
  • 13.15. Saudi Arabia
  • 13.16. South Africa
  • 13.17. Spain
  • 13.18. Sweden
  • 13.19. Switzerland
  • 13.20. Turkey
  • 13.21. United Arab Emirates
  • 13.22. United Kingdom

14. Competitive Landscape

  • 14.1. Market Share Analysis, 2024
  • 14.2. FPNV Positioning Matrix, 2024
  • 14.3. Competitive Scenario Analysis
    • 14.3.1. Bentley enhances vascular offerings with expanded FEVAR indication for BeGraft and the launch of BeFlared bridging stent
    • 14.3.2. Terumo India unveils innovative Treo Abdominal Stent Graft System
    • 14.3.3. PexaLabs' EXGraft vascular grafts gain expanded CE mark
    • 14.3.4. Aquedeon Medical, Inc. Receives FDA IDE Approval for the Duett Vascular Graft System
    • 14.3.5. Xeltis' aXess Vascular Graft Development Receives Funding From European Innovation Council
    • 14.3.6. Vygon Partners with Carmat to Develop a Vascular Graft for an Artificial Heart
  • 14.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Abbott Laboratories
  • 2. Affluent Medical
  • 3. B. Braun Melsungen AG
  • 4. Becton, Dickinson and Company
  • 5. BIOVIC Sdn. Bhd.
  • 6. Boston Scientific Corporation
  • 7. Cardinal Health Inc.
  • 8. Cook Medical, Inc.
  • 9. Corcym S.r.l.
  • 10. CryoLife, Inc.
  • 11. Endologix Inc.
  • 12. Getinge AB
  • 13. Heart Medical Europe B.V.
  • 14. Japan Lifeline Co., Ltd.
  • 15. Lemaitre Vascular, Inc.
  • 16. Medtronic PLC
  • 17. Merit Medical Systems, Inc.
  • 18. Perouse Medical SAS by Vygon SAS
  • 19. Rua Life Sciences PLC
  • 20. Shanghai Suokang Medical Implants Co. Ltd.
  • 21. Terumo Corporation
  • 22. Vascular Graft Solutions Ltd.
  • 23. VUP Medical
  • 24. W. L. Gore & Associates, Inc.
  • 25. Xeltis B.V.

LIST OF FIGURES

  • FIGURE 1. VASCULAR GRAFT MARKET MULTI-CURRENCY
  • FIGURE 2. VASCULAR GRAFT MARKET MULTI-LANGUAGE
  • FIGURE 3. VASCULAR GRAFT MARKET RESEARCH PROCESS
  • FIGURE 4. VASCULAR GRAFT MARKET SIZE, 2024 VS 2030
  • FIGURE 5. GLOBAL VASCULAR GRAFT MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 6. GLOBAL VASCULAR GRAFT MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 7. GLOBAL VASCULAR GRAFT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL VASCULAR GRAFT MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
  • FIGURE 9. GLOBAL VASCULAR GRAFT MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL VASCULAR GRAFT MARKET SIZE, BY BLOOD VESSEL DIAMETER, 2024 VS 2030 (%)
  • FIGURE 11. GLOBAL VASCULAR GRAFT MARKET SIZE, BY BLOOD VESSEL DIAMETER, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL VASCULAR GRAFT MARKET SIZE, BY INDICATION, 2024 VS 2030 (%)
  • FIGURE 13. GLOBAL VASCULAR GRAFT MARKET SIZE, BY INDICATION, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 14. GLOBAL VASCULAR GRAFT MARKET SIZE, BY END USER, 2024 VS 2030 (%)
  • FIGURE 15. GLOBAL VASCULAR GRAFT MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 16. GLOBAL VASCULAR GRAFT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
  • FIGURE 17. GLOBAL VASCULAR GRAFT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 18. AMERICAS VASCULAR GRAFT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 19. AMERICAS VASCULAR GRAFT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 20. UNITED STATES VASCULAR GRAFT MARKET SIZE, BY STATE, 2024 VS 2030 (%)
  • FIGURE 21. UNITED STATES VASCULAR GRAFT MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 22. ASIA-PACIFIC VASCULAR GRAFT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 23. ASIA-PACIFIC VASCULAR GRAFT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 24. EUROPE, MIDDLE EAST & AFRICA VASCULAR GRAFT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 25. EUROPE, MIDDLE EAST & AFRICA VASCULAR GRAFT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 26. VASCULAR GRAFT MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 27. VASCULAR GRAFT MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. VASCULAR GRAFT MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL VASCULAR GRAFT MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL VASCULAR GRAFT MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL VASCULAR GRAFT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. VASCULAR GRAFT MARKET DYNAMICS
  • TABLE 7. GLOBAL VASCULAR GRAFT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL VASCULAR GRAFTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL VASCULAR GRAFT MARKET SIZE, BY ALLOGRAFTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL VASCULAR GRAFT MARKET SIZE, BY AUTOGRAFTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL VASCULAR GRAFT MARKET SIZE, BY XENOGRAFTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL VASCULAR GRAFTS, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL VASCULAR GRAFT MARKET SIZE, BY SYNTHETIC VASCULAR GRAFTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL VASCULAR GRAFT MARKET SIZE, BY POLYESTER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL VASCULAR GRAFT MARKET SIZE, BY POLYTETRAFLUOROETHYLENE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL VASCULAR GRAFT MARKET SIZE, BY POLYURETHANE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL VASCULAR GRAFT MARKET SIZE, BY SYNTHETIC VASCULAR GRAFTS, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL VASCULAR GRAFT MARKET SIZE, BY BLOOD VESSEL DIAMETER, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL VASCULAR GRAFT MARKET SIZE, BY LARGE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL VASCULAR GRAFT MARKET SIZE, BY SMALL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL VASCULAR GRAFT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL VASCULAR GRAFT MARKET SIZE, BY AORTOILIAC BYPASS SURGERY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL VASCULAR GRAFT MARKET SIZE, BY CEREBRAL ARTERY BYPASS SURGERY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL VASCULAR GRAFT MARKET SIZE, BY CORONARY ARTERY BYPASS SURGERY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL VASCULAR GRAFT MARKET SIZE, BY LOWER EXTREMITY BYPASS SURGERY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL VASCULAR GRAFT MARKET SIZE, BY PERIPHERAL ARTERY BYPASS SURGERY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL VASCULAR GRAFT MARKET SIZE, BY RENAL ARTERY BYPASS SURGERY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL VASCULAR GRAFT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL VASCULAR GRAFT MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL VASCULAR GRAFT MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 31. GLOBAL VASCULAR GRAFT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 32. GLOBAL VASCULAR GRAFT MARKET SIZE, BY OFFLINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 33. GLOBAL VASCULAR GRAFT MARKET SIZE, BY ONLINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 34. AMERICAS VASCULAR GRAFT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 35. AMERICAS VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL VASCULAR GRAFTS, 2018-2030 (USD MILLION)
  • TABLE 36. AMERICAS VASCULAR GRAFT MARKET SIZE, BY SYNTHETIC VASCULAR GRAFTS, 2018-2030 (USD MILLION)
  • TABLE 37. AMERICAS VASCULAR GRAFT MARKET SIZE, BY BLOOD VESSEL DIAMETER, 2018-2030 (USD MILLION)
  • TABLE 38. AMERICAS VASCULAR GRAFT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 39. AMERICAS VASCULAR GRAFT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 40. AMERICAS VASCULAR GRAFT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 41. AMERICAS VASCULAR GRAFT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 42. ARGENTINA VASCULAR GRAFT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 43. ARGENTINA VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL VASCULAR GRAFTS, 2018-2030 (USD MILLION)
  • TABLE 44. ARGENTINA VASCULAR GRAFT MARKET SIZE, BY SYNTHETIC VASCULAR GRAFTS, 2018-2030 (USD MILLION)
  • TABLE 45. ARGENTINA VASCULAR GRAFT MARKET SIZE, BY BLOOD VESSEL DIAMETER, 2018-2030 (USD MILLION)
  • TABLE 46. ARGENTINA VASCULAR GRAFT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 47. ARGENTINA VASCULAR GRAFT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 48. ARGENTINA VASCULAR GRAFT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 49. BRAZIL VASCULAR GRAFT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 50. BRAZIL VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL VASCULAR GRAFTS, 2018-2030 (USD MILLION)
  • TABLE 51. BRAZIL VASCULAR GRAFT MARKET SIZE, BY SYNTHETIC VASCULAR GRAFTS, 2018-2030 (USD MILLION)
  • TABLE 52. BRAZIL VASCULAR GRAFT MARKET SIZE, BY BLOOD VESSEL DIAMETER, 2018-2030 (USD MILLION)
  • TABLE 53. BRAZIL VASCULAR GRAFT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 54. BRAZIL VASCULAR GRAFT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 55. BRAZIL VASCULAR GRAFT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 56. CANADA VASCULAR GRAFT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 57. CANADA VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL VASCULAR GRAFTS, 2018-2030 (USD MILLION)
  • TABLE 58. CANADA VASCULAR GRAFT MARKET SIZE, BY SYNTHETIC VASCULAR GRAFTS, 2018-2030 (USD MILLION)
  • TABLE 59. CANADA VASCULAR GRAFT MARKET SIZE, BY BLOOD VESSEL DIAMETER, 2018-2030 (USD MILLION)
  • TABLE 60. CANADA VASCULAR GRAFT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 61. CANADA VASCULAR GRAFT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 62. CANADA VASCULAR GRAFT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 63. MEXICO VASCULAR GRAFT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 64. MEXICO VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL VASCULAR GRAFTS, 2018-2030 (USD MILLION)
  • TABLE 65. MEXICO VASCULAR GRAFT MARKET SIZE, BY SYNTHETIC VASCULAR GRAFTS, 2018-2030 (USD MILLION)
  • TABLE 66. MEXICO VASCULAR GRAFT MARKET SIZE, BY BLOOD VESSEL DIAMETER, 2018-2030 (USD MILLION)
  • TABLE 67. MEXICO VASCULAR GRAFT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 68. MEXICO VASCULAR GRAFT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 69. MEXICO VASCULAR GRAFT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 70. UNITED STATES VASCULAR GRAFT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 71. UNITED STATES VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL VASCULAR GRAFTS, 2018-2030 (USD MILLION)
  • TABLE 72. UNITED STATES VASCULAR GRAFT MARKET SIZE, BY SYNTHETIC VASCULAR GRAFTS, 2018-2030 (USD MILLION)
  • TABLE 73. UNITED STATES VASCULAR GRAFT MARKET SIZE, BY BLOOD VESSEL DIAMETER, 2018-2030 (USD MILLION)
  • TABLE 74. UNITED STATES VASCULAR GRAFT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 75. UNITED STATES VASCULAR GRAFT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 76. UNITED STATES VASCULAR GRAFT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 77. UNITED STATES VASCULAR GRAFT MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 78. ASIA-PACIFIC VASCULAR GRAFT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 79. ASIA-PACIFIC VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL VASCULAR GRAFTS, 2018-2030 (USD MILLION)
  • TABLE 80. ASIA-PACIFIC VASCULAR GRAFT MARKET SIZE, BY SYNTHETIC VASCULAR GRAFTS, 2018-2030 (USD MILLION)
  • TABLE 81. ASIA-PACIFIC VASCULAR GRAFT MARKET SIZE, BY BLOOD VESSEL DIAMETER, 2018-2030 (USD MILLION)
  • TABLE 82. ASIA-PACIFIC VASCULAR GRAFT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 83. ASIA-PACIFIC VASCULAR GRAFT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 84. ASIA-PACIFIC VASCULAR GRAFT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 85. ASIA-PACIFIC VASCULAR GRAFT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 86. AUSTRALIA VASCULAR GRAFT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 87. AUSTRALIA VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL VASCULAR GRAFTS, 2018-2030 (USD MILLION)
  • TABLE 88. AUSTRALIA VASCULAR GRAFT MARKET SIZE, BY SYNTHETIC VASCULAR GRAFTS, 2018-2030 (USD MILLION)
  • TABLE 89. AUSTRALIA VASCULAR GRAFT MARKET SIZE, BY BLOOD VESSEL DIAMETER, 2018-2030 (USD MILLION)
  • TABLE 90. AUSTRALIA VASCULAR GRAFT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 91. AUSTRALIA VASCULAR GRAFT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 92. AUSTRALIA VASCULAR GRAFT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 93. CHINA VASCULAR GRAFT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 94. CHINA VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL VASCULAR GRAFTS, 2018-2030 (USD MILLION)
  • TABLE 95. CHINA VASCULAR GRAFT MARKET SIZE, BY SYNTHETIC VASCULAR GRAFTS, 2018-2030 (USD MILLION)
  • TABLE 96. CHINA VASCULAR GRAFT MARKET SIZE, BY BLOOD VESSEL DIAMETER, 2018-2030 (USD MILLION)
  • TABLE 97. CHINA VASCULAR GRAFT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 98. CHINA VASCULAR GRAFT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 99. CHINA VASCULAR GRAFT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 100. INDIA VASCULAR GRAFT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 101. INDIA VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL VASCULAR GRAFTS, 2018-2030 (USD MILLION)
  • TABLE 102. INDIA VASCULAR GRAFT MARKET SIZE, BY SYNTHETIC VASCULAR GRAFTS, 2018-2030 (USD MILLION)
  • TABLE 103. INDIA VASCULAR GRAFT MARKET SIZE, BY BLOOD VESSEL DIAMETER, 2018-2030 (USD MILLION)
  • TABLE 104. INDIA VASCULAR GRAFT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 105. INDIA VASCULAR GRAFT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 106. INDIA VASCULAR GRAFT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 107. INDONESIA VASCULAR GRAFT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 108. INDONESIA VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL VASCULAR GRAFTS, 2018-2030 (USD MILLION)
  • TABLE 109. INDONESIA VASCULAR GRAFT MARKET SIZE, BY SYNTHETIC VASCULAR GRAFTS, 2018-2030 (USD MILLION)
  • TABLE 110. INDONESIA VASCULAR GRAFT MARKET SIZE, BY BLOOD VESSEL DIAMETER, 2018-2030 (USD MILLION)
  • TABLE 111. INDONESIA VASCULAR GRAFT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 112. INDONESIA VASCULAR GRAFT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 113. INDONESIA VASCULAR GRAFT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 114. JAPAN VASCULAR GRAFT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 115. JAPAN VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL VASCULAR GRAFTS, 2018-2030 (USD MILLION)
  • TABLE 116. JAPAN VASCULAR GRAFT MARKET SIZE, BY SYNTHETIC VASCULAR GRAFTS, 2018-2030 (USD MILLION)
  • TABLE 117. JAPAN VASCULAR GRAFT MARKET SIZE, BY BLOOD VESSEL DIAMETER, 2018-2030 (USD MILLION)
  • TABLE 118. JAPAN VASCULAR GRAFT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 119. JAPAN VASCULAR GRAFT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 120. JAPAN VASCULAR GRAFT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 121. MALAYSIA VASCULAR GRAFT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 122. MALAYSIA VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL VASCULAR GRAFTS, 2018-2030 (USD MILLION)
  • TABLE 123. MALAYSIA VASCULAR GRAFT MARKET SIZE, BY SYNTHETIC VASCULAR GRAFTS, 2018-2030 (USD MILLION)
  • TABLE 124. MALAYSIA VASCULAR GRAFT MARKET SIZE, BY BLOOD VESSEL DIAMETER, 2018-2030 (USD MILLION)
  • TABLE 125. MALAYSIA VASCULAR GRAFT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 126. MALAYSIA VASCULAR GRAFT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 127. MALAYSIA VASCULAR GRAFT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 128. PHILIPPINES VASCULAR GRAFT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 129. PHILIPPINES VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL VASCULAR GRAFTS, 2018-2030 (USD MILLION)
  • TABLE 130. PHILIPPINES VASCULAR GRAFT MARKET SIZE, BY SYNTHETIC VASCULAR GRAFTS, 2018-2030 (USD MILLION)
  • TABLE 131. PHILIPPINES VASCULAR GRAFT MARKET SIZE, BY BLOOD VESSEL DIAMETER, 2018-2030 (USD MILLION)
  • TABLE 132. PHILIPPINES VASCULAR GRAFT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 133. PHILIPPINES VASCULAR GRAFT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 134. PHILIPPINES VASCULAR GRAFT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 135. SINGAPORE VASCULAR GRAFT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 136. SINGAPORE VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL VASCULAR GRAFTS, 2018-2030 (USD MILLION)
  • TABLE 137. SINGAPORE VASCULAR GRAFT MARKET SIZE, BY SYNTHETIC VASCULAR GRAFTS, 2018-2030 (USD MILLION)
  • TABLE 138. SINGAPORE VASCULAR GRAFT MARKET SIZE, BY BLOOD VESSEL DIAMETER, 2018-2030 (USD MILLION)
  • TABLE 139. SINGAPORE VASCULAR GRAFT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 140. SINGAPORE VASCULAR GRAFT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 141. SINGAPORE VASCULAR GRAFT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 142. SOUTH KOREA VASCULAR GRAFT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 143. SOUTH KOREA VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL VASCULAR GRAFTS, 2018-2030 (USD MILLION)
  • TABLE 144. SOUTH KOREA VASCULAR GRAFT MARKET SIZE, BY SYNTHETIC VASCULAR GRAFTS, 2018-2030 (USD MILLION)
  • TABLE 145. SOUTH KOREA VASCULAR GRAFT MARKET SIZE, BY BLOOD VESSEL DIAMETER, 2018-2030 (USD MILLION)
  • TABLE 146. SOUTH KOREA VASCULAR GRAFT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 147. SOUTH KOREA VASCULAR GRAFT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 148. SOUTH KOREA VASCULAR GRAFT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 149. TAIWAN VASCULAR GRAFT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 150. TAIWAN VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL VASCULAR GRAFTS, 2018-2030 (USD MILLION)
  • TABLE 151. TAIWAN VASCULAR GRAFT MARKET SIZE, BY SYNTHETIC VASCULAR GRAFTS, 2018-2030 (USD MILLION)
  • TABLE 152. TAIWAN VASCULAR GRAFT MARKET SIZE, BY BLOOD VESSEL DIAMETER, 2018-2030 (USD MILLION)
  • TABLE 153. TAIWAN VASCULAR GRAFT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 154. TAIWAN VASCULAR GRAFT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 155. TAIWAN VASCULAR GRAFT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 156. THAILAND VASCULAR GRAFT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 157. THAILAND VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL VASCULAR GRAFTS, 2018-2030 (USD MILLION)
  • TABLE 158. THAILAND VASCULAR GRAFT MARKET SIZE, BY SYNTHETIC VASCULAR GRAFTS, 2018-2030 (USD MILLION)
  • TABLE 159. THAILAND VASCULAR GRAFT MARKET SIZE, BY BLOOD VESSEL DIAMETER, 2018-2030 (USD MILLION)
  • TABLE 160. THAILAND VASCULAR GRAFT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 161. THAILAND VASCULAR GRAFT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 162. THAILAND VASCULAR GRAFT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 163. VIETNAM VASCULAR GRAFT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 164. VIETNAM VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL VASCULAR GRAFTS, 2018-2030 (USD MILLION)
  • TABLE 165. VIETNAM VASCULAR GRAFT MARKET SIZE, BY SYNTHETIC VASCULAR GRAFTS, 2018-2030 (USD MILLION)
  • TABLE 166. VIETNAM VASCULAR GRAFT MARKET SIZE, BY BLOOD VESSEL DIAMETER, 2018-2030 (USD MILLION)
  • TABLE 167. VIETNAM VASCULAR GRAFT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 168. VIETNAM VASCULAR GRAFT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 169. VIETNAM VASCULAR GRAFT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 170. EUROPE, MIDDLE EAST & AFRICA VASCULAR GRAFT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 171. EUROPE, MIDDLE EAST & AFRICA VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL VASCULAR GRAFTS, 2018-2030 (USD MILLION)
  • TABLE 172. EUROPE, MIDDLE EAST & AFRICA VASCULAR GRAFT MARKET SIZE, BY SYNTHETIC VASCULAR GRAFTS, 2018-2030 (USD MILLION)
  • TABLE 173. EUROPE, MIDDLE EAST & AFRICA VASCULAR GRAFT MARKET SIZE, BY BLOOD VESSEL DIAMETER, 2018-2030 (USD MILLION)
  • TABLE 174. EUROPE, MIDDLE EAST & AFRICA VASCULAR GRAFT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 175. EUROPE, MIDDLE EAST & AFRICA VASCULAR GRAFT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 176. EUROPE, MIDDLE EAST & AFRICA VASCULAR GRAFT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 177. EUROPE, MIDDLE EAST & AFRICA VASCULAR GRAFT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 178. DENMARK VASCULAR GRAFT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 179. DENMARK VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL VASCULAR GRAFTS, 2018-2030 (USD MILLION)
  • TABLE 180. DENMARK VASCULAR GRAFT MARKET SIZE, BY SYNTHETIC VASCULAR GRAFTS, 2018-2030 (USD MILLION)
  • TABLE 181. DENMARK VASCULAR GRAFT MARKET SIZE, BY BLOOD VESSEL DIAMETER, 2018-2030 (USD MILLION)
  • TABLE 182. DENMARK VASCULAR GRAFT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 183. DENMARK VASCULAR GRAFT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 184. DENMARK VASCULAR GRAFT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 185. EGYPT VASCULAR GRAFT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 186. EGYPT VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL VASCULAR GRAFTS, 2018-2030 (USD MILLION)
  • TABLE 187. EGYPT VASCULAR GRAFT MARKET SIZE, BY SYNTHETIC VASCULAR GRAFTS, 2018-2030 (USD MILLION)
  • TABLE 188. EGYPT VASCULAR GRAFT MARKET SIZE, BY BLOOD VESSEL DIAMETER, 2018-2030 (USD MILLION)
  • TABLE 189. EGYPT VASCULAR GRAFT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 190. EGYPT VASCULAR GRAFT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 191. EGYPT VASCULAR GRAFT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 192. FINLAND VASCULAR GRAFT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 193. FINLAND VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL VASCULAR GRAFTS, 2018-2030 (USD MILLION)
  • TABLE 194. FINLAND VASCULAR GRAFT MARKET SIZE, BY SYNTHETIC VASCULAR GRAFTS, 2018-2030 (USD MILLION)
  • TABLE 195. FINLAND VASCULAR GRAFT MARKET SIZE, BY BLOOD VESSEL DIAMETER, 2018-2030 (USD MILLION)
  • TABLE 196. FINLAND VASCULAR GRAFT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 197. FINLAND VASCULAR GRAFT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 198. FINLAND VASCULAR GRAFT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 199. FRANCE VASCULAR GRAFT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 200. FRANCE VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL VASCULAR GRAFTS, 2018-2030 (USD MILLION)
  • TABLE 201. FRANCE VASCULAR GRAFT MARKET SIZE, BY SYNTHETIC VASCULAR GRAFTS, 2018-2030 (USD MILLION)
  • TABLE 202. FRANCE VASCULAR GRAFT MARKET SIZE, BY BLOOD VESSEL DIAMETER, 2018-2030 (USD MILLION)
  • TABLE 203. FRANCE VASCULAR GRAFT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 204. FRANCE VASCULAR GRAFT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 205. FRANCE VASCULAR GRAFT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 206. GERMANY VASCULAR GRAFT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 207. GERMANY VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL VASCULAR GRAFTS, 2018-2030 (USD MILLION)
  • TABLE 208. GERMANY VASCULAR GRAFT MARKET SIZE, BY SYNTHETIC VASCULAR GRAFTS, 2018-2030 (USD MILLION)
  • TABLE 209. GERMANY VASCULAR GRAFT MARKET SIZE, BY BLOOD VESSEL DIAMETER, 2018-2030 (USD MILLION)
  • TABLE 210. GERMANY VASCULAR GRAFT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 211. GERMANY VASCULAR GRAFT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 212. GERMANY VASCULAR GRAFT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 213. ISRAEL VASCULAR GRAFT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 214. ISRAEL VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL VASCULAR GRAFTS, 2018-2030 (USD MILLION)
  • TABLE 215. ISRAEL VASCULAR GRAFT MARKET SIZE, BY SYNTHETIC VASCULAR GRAFTS, 2018-2030 (USD MILLION)
  • TABLE 216. ISRAEL VASCULAR GRAFT MARKET SIZE, BY BLOOD VESSEL DIAMETER, 2018-2030 (USD MILLION)
  • TABLE 217. ISRAEL VASCULAR GRAFT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 218. ISRAEL VASCULAR GRAFT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 219. ISRAEL VASCULAR GRAFT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 220. ITALY VASCULAR GRAFT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 221. ITALY VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL VASCULAR GRAFTS, 2018-2030 (USD MILLION)
  • TABLE 222. ITALY VASCULAR GRAFT MARKET SIZE, BY SYNTHETIC VASCULAR GRAFTS, 2018-2030 (USD MILLION)
  • TABLE 223. ITALY VASCULAR GRAFT MARKET SIZE, BY BLOOD VESSEL DIAMETER, 2018-2030 (USD MILLION)
  • TABLE 224. ITALY VASCULAR GRAFT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 225. ITALY VASCULAR GRAFT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 226. ITALY VASCULAR GRAFT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 227. NETHERLANDS VASCULAR GRAFT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 228. NETHERLANDS VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL VASCULAR GRAFTS, 2018-2030 (USD MILLION)
  • TABLE 229. NETHERLANDS VASCULAR GRAFT MARKET SIZE, BY SYNTHETIC VASCULAR GRAFTS, 2018-2030 (USD MILLION)
  • TABLE 230. NETHERLANDS VASCULAR GRAFT MARKET SIZE, BY BLOOD VESSEL DIAMETER, 2018-2030 (USD MILLION)
  • TABLE 231. NETHERLANDS VASCULAR GRAFT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 232. NETHERLANDS VASCULAR GRAFT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 233. NETHERLANDS VASCULAR GRAFT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 234. NIGERIA VASCULAR GRAFT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 235. NIGERIA VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL VASCULAR GRAFTS, 2018-2030 (USD MILLION)
  • TABLE 236. NIGERIA VASCULAR GRAFT MARKET SIZE, BY SYNTHETIC VASCULAR GRAFTS, 2018-2030 (USD MILLION)
  • TABLE 237. NIGERIA VASCULAR GRAFT MARKET SIZE, BY BLOOD VESSEL DIAMETER, 2018-2030 (USD MILLION)
  • TABLE 238. NIGERIA VASCULAR GRAFT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 239. NIGERIA VASCULAR GRAFT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 240. NIGERIA VASCULAR GRAFT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 241. NORWAY VASCULAR GRAFT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 242. NORWAY VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL VASCULAR GRAFTS, 2018-2030 (USD MILLION)
  • TABLE 243. NORWAY VASCULAR GRAFT MARKET SIZE, BY SYNTHETIC VASCULAR GRAFTS, 2018-2030 (USD MILLION)
  • TABLE 244. NORWAY VASCULAR GRAFT MARKET SIZE, BY BLOOD VESSEL DIAMETER, 2018-2030 (USD MILLION)
  • TABLE 245. NORWAY VASCULAR GRAFT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 246. NORWAY VASCULAR GRAFT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 247. NORWAY VASCULAR GRAFT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 248. POLAND VASCULAR GRAFT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 249. POLAND VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL VASCULAR GRAFTS, 2018-2030 (USD MILLION)
  • TABLE 250. POLAND VASCULAR GRAFT MARKET SIZE, BY SYNTHETIC VASCULAR GRAFTS, 2018-2030 (USD MILLION)
  • TABLE 251. POLAND VASCULAR GRAFT MARKET SIZE, BY BLOOD VESSEL DIAMETER, 2018-2030 (USD MILLION)
  • TABLE 252. POLAND VASCULAR GRAFT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 253. POLAND VASCULAR GRAFT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 254. POLAND VASCULAR GRAFT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 255. QATAR VASCULAR GRAFT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 256. QATAR VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL VASCULAR GRAFTS, 2018-2030 (USD MILLION)
  • TABLE 257. QATAR VASCULAR GRAFT MARKET SIZE, BY SYNTHETIC VASCULAR GRAFTS, 2018-2030 (USD MILLION)
  • TABLE 258. QATAR VASCULAR GRAFT MARKET SIZE, BY BLOOD VESSEL DIAMETER, 2018-2030 (USD MILLION)
  • TABLE 259. QATAR VASCULAR GRAFT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 260. QATAR VASCULAR GRAFT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 261. QATAR VASCULAR GRAFT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 262. RUSSIA VASCULAR GRAFT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 263. RUSSIA VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL VASCULAR GRAFTS, 2018-2030 (USD MILLION)
  • TABLE 264. RUSSIA VASCULAR GRAFT MARKET SIZE, BY SYNTHETIC VASCULAR GRAFTS, 2018-2030 (USD MILLION)
  • TABLE 265. RUSSIA VASCULAR GRAFT MARKET SIZE, BY BLOOD VESSEL DIAMETER, 2018-2030 (USD MILLION)
  • TABLE 266. RUSSIA VASCULAR GRAFT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 267. RUSSIA VASCULAR GRAFT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 268. RUSSIA VASCULAR GRAFT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 269. SAUDI ARABIA VASCULAR GRAFT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 270. SAUDI ARABIA VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL VASCULAR GRAFTS, 2018-2030 (USD MILLION)
  • TABLE 271. SAUDI ARABIA VASCULAR GRAFT MARKET SIZE, BY SYNTHETIC VASCULAR GRAFTS, 2018-2030 (USD MILLION)
  • TABLE 272. SAUDI ARABIA VASCULAR GRAFT MARKET SIZE, BY BLOOD VESSEL DIAMETER, 2018-2030 (USD MILLION)
  • TABLE 273. SAUDI ARABIA VASCULAR GRAFT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 274. SAUDI ARABIA VASCULAR GRAFT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 275. SAUDI ARABIA VASCULAR GRAFT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 276. SOUTH AFRICA VASCULAR GRAFT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 277. SOUTH AFRICA VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL VASCULAR GRAFTS, 2018-2030 (USD MILLION)
  • TABLE 278. SOUTH AFRICA VASCULAR GRAFT MARKET SIZE, BY SYNTHETIC VASCULAR GRAFTS, 2018-2030 (USD MILLION)
  • TABLE 279. SOUTH AFRICA VASCULAR GRAFT MARKET SIZE, BY BLOOD VESSEL DIAMETER, 2018-2030 (USD MILLION)
  • TABLE 280. SOUTH AFRICA VASCULAR GRAFT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 281. SOUTH AFRICA VASCULAR GRAFT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 282. SOUTH AFRICA VASCULAR GRAFT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 283. SPAIN VASCULAR GRAFT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 284. SPAIN VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL VASCULAR GRAFTS, 2018-2030 (USD MILLION)
  • TABLE 285. SPAIN VASCULAR GRAFT MARKET SIZE, BY SYNTHETIC VASCULAR GRAFTS, 2018-2030 (USD MILLION)
  • TABLE 286. SPAIN VASCULAR GRAFT MARKET SIZE, BY BLOOD VESSEL DIAMETER, 2018-2030 (USD MILLION)
  • TABLE 287. SPAIN VASCULAR GRAFT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 288. SPAIN VASCULAR GRAFT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 289. SPAIN VASCULAR GRAFT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 290. SWEDEN VASCULAR GRAFT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 291. SWEDEN VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL VASCULAR GRAFTS, 2018-2030 (USD MILLION)
  • TABLE 292. SWEDEN VASCULAR GRAFT MARKET SIZE, BY SYNTHETIC VASCULAR GRAFTS, 2018-2030 (USD MILLION)
  • TABLE 293. SWEDEN VASCULAR GRAFT MARKET SIZE, BY BLOOD VESSEL DIAMETER, 2018-2030 (USD MILLION)
  • TABLE 294. SWEDEN VASCULAR GRAFT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 295. SWEDEN VASCULAR GRAFT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 296. SWEDEN VASCULAR GRAFT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 297. SWITZERLAND VASCULAR GRAFT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 298. SWITZERLAND VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL VASCULAR GRAFTS, 2018-2030 (USD MILLION)
  • TABLE 299. SWITZERLAND VASCULAR GRAFT MARKET SIZE, BY SYNTHETIC VASCULAR GRAFTS, 2018-2030 (USD MILLION)
  • TABLE 300. SWITZERLAND VASCULAR GRAFT MARKET SIZE, BY BLOOD VESSEL DIAMETER, 2018-2030 (USD MILLION)
  • TABLE 301. SWITZERLAND VASCULAR GRAFT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 302. SWITZERLAND VASCULAR GRAFT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 303. SWITZERLAND VASCULAR GRAFT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 304. TURKEY VASCULAR GRAFT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 305. TURKEY VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL VASCULAR GRAFTS, 2018-2030 (USD MILLION)
  • TABLE 306. TURKEY VASCULAR GRAFT MARKET SIZE, BY SYNTHETIC VASCULAR GRAFTS, 2018-2030 (USD MILLION)
  • TABLE 307. TURKEY VASCULAR GRAFT MARKET SIZE, BY BLOOD VESSEL DIAMETER, 2018-2030 (USD MILLION)
  • TABLE 308. TURKEY VASCULAR GRAFT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 309. TURKEY VASCULAR GRAFT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 310. TURKEY VASCULAR GRAFT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 311. UNITED ARAB EMIRATES VASCULAR GRAFT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 312. UNITED ARAB EMIRATES VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL VASCULAR GRAFTS, 2018-2030 (USD MILLION)
  • TABLE 313. UNITED ARAB EMIRATES VASCULAR GRAFT MARKET SIZE, BY SYNTHETIC VASCULAR GRAFTS, 2018-2030 (USD MILLION)
  • TABLE 314. UNITED ARAB EMIRATES VASCULAR GRAFT MARKET SIZE, BY BLOOD VESSEL DIAMETER, 2018-2030 (USD MILLION)
  • TABLE 315. UNITED ARAB EMIRATES VASCULAR GRAFT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 316. UNITED ARAB EMIRATES VASCULAR GRAFT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 317. UNITED ARAB EMIRATES VASCULAR GRAFT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 318. UNITED KINGDOM VASCULAR GRAFT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 319. UNITED KINGDOM VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL VASCULAR GRAFTS, 2018-2030 (USD MILLION)
  • TABLE 320. UNITED KINGDOM VASCULAR GRAFT MARKET SIZE, BY SYNTHETIC VASCULAR GRAFTS, 2018-2030 (USD MILLION)
  • TABLE 321. UNITED KINGDOM VASCULAR GRAFT MARKET SIZE, BY BLOOD VESSEL DIAMETER, 2018-2030 (USD MILLION)
  • TABLE 322. UNITED KINGDOM VASCULAR GRAFT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 323. UNITED KINGDOM VASCULAR GRAFT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 324. UNITED KINGDOM VASCULAR GRAFT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 325. VASCULAR GRAFT MARKET SHARE, BY KEY PLAYER, 2024
  • TABLE 326. VASCULAR GRAFT MARKET, FPNV POSITIONING MATRIX, 2024